Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Description

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Conditions

Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B, Hepatitis C, Diabetes, COPD

Talk to us

Study Overview

On this page

Study Details

Study overview

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Redondo Beach

Torrance Memorial Physician Network - Cancer Care, Redondo Beach, California, United States, 90277

Coon Rapids

Allina Health, Virginia Piper Cancer Institute, Coon Rapids, Minnesota, United States, 55433

Fridley

Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley, Minnesota, United States, 55432

Minneapolis

VPCI Oncology Research, Minneapolis, Minnesota, United States, 55407

Memphis

Methodist LeBonheur Healthcare, Memphis, Tennessee, United States, 38104

Dallas

Liver Center of Texas, Dallas, Texas, United States, 75234

Richardson

Methodist Hospital, Richardson, Texas, United States, 75082

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 2.1.1 Age 18 years or older.
  • 2.1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
  • 2.2.1 Patients that are unwilling or unable to sign the Informed Consent Form will be excluded.
  • 2.2.2 Approximately 50 mL of blood will be drawn from participants within an 8-week period under this protocol. Patients that have already given 50 mL of blood within this time frame will be excluded.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Helio Genomics,

Taggert, STUDY_DIRECTOR, Helio Health

Study Record Dates

2025-12